Ch. 15 Hypersensitivities Flashcards
What is the word origin for the word “allergy”?
Allos= "other" Ergon= "reaction"
Why was research into type I hypersensitivities delayed for eyars?
free circulating IgE is usually very low in concentration in blood serum; experiments did not take place until discovery of IgE-producing myeloma
Describe the antigens that are usually repsonsible for type I hypersensitivities
- most are proteins or glycoproteins
- most possess many antigenic sites (epitopes) per molecule
- often have intrinsic enzymatic proteins
- many contain potential PAMPs, stimulating innate immunity through interactions with PRRs
What is the mechanism behind the development of type I hypersensitivity?
- exposure to antigen activates TH2 cells and stimulates B cells to become IgE plasma cells
- secreted IgE binds to FcεRs (receptors on granulocytes for IgE constant region)
- second exposure to allergen crosslinks FcεRs/IgE complexes and induces degranulatioin
Summarize how the primary inflammatory mediator, histamine, contributes to the signs and symptoms of type I hypersensitivity.
- effects within minutes
- binds to one of four possible histamine receptors
- H1: induces contraction of intestinal and bronchial smooth muscles, increased permeability of venules, and mucous secretion
- H4: binding on mast cells promotes their chemotaxis to sites of finfection/allergy
Summarize how the secondary inflammatory mediators, leukotrienes and prostaglandins, contribute to the signs and symptoms of type I hypersensitivity
-initiated by mast cell degranulation
-initial contraction of bronchial and tracheal smooth muscles is by histamine
-after 30-60s, further contraction is activated by leukotrienes and prostaglandins produced by mast cell degranulation
considered to be major cause of bronchospasm and mucus buildup in asthma suffers
IL-$ and IL-3 secondary mediators
stimulate TH2 responses to increase IgE production by B cells
IL-5 secondary mediator
recruits and activates eosinophils
IL-8 secondary mediator
acts as a chemotactic factor, attracting other cells
GM-CSF secondary mediator
stimulates production and activation of more myeloid cells, including more granulocytes
Early Phase Type I hypersensitivity response
- responses occur within minutes of allergen exposure
- mediated by mast cell granule contents (histamine, leukotrienes, prostaglandins)
Late Phase Type I Hypersensitvity response
- responses occur hours later, a result of recruited cells
- often inflammatory cell types such as neutrophils
Why does an EpiPen work to halt anaphylaxis?
counteracts effects of histamine and leukotrienes, relaxing smooth muscles in airways and reducing vascular permeability
improves CO, avoiding vascular collapse during anaphylactic reactions
What types of gne products are implicated in a genetic cause of type I hypersensitivities?
- proteins involved in generation and regulation of immune responsiveness (innate immune receptors, cytokines/chemokines, and their receptors, MHC proteins
- proteins involved in maintaining epithelial barrier integrity (growth factors, proteolytic enzymes)
- proteins involved in activating allergic responses (FCERI, growth factors, etc)
What types of environmental triggers can increase or decrease an individual’s risk for developing allergies?
- air pollution (cigarette smoke, diesel truck exhaust, factor fumes)
- exposure to a range of bacteria (decreases risk)
- diet also linked to risks of developing allergy
Skin testing in allergy identification
- injects small quantities of known allergens under skin
- swelling and redness indicate allergic response
4 types of treatment of allergy
- drugs that reduce symptoms
- medications that reduce allergic asthma and anaphylaxis
- Immunotherapeutics
- desensitization/immunotherapy
Drugs that reduce allergic symptoms
- antihistamines, leukotriene antagonists, and inhalation corticosteroids
- antihistamines bind and block H1 receptors on target cells
- leukotriene antagonists work in a manner similar to antihistamines
- inhalation corticosteroids inhibit innate immune cell activity in airways, treating asthma
Medications that reduce allergic asthma and anaphylaxis
- block degranulation of mast cells or counter bronchoconstriction
- epinephrine or epinephrine agonists (like albuterol)
Immunotherapeutics
Anti-IgE antibodies that bind to IgE and inhibit IgE binding to FceR molecules
- one approved by the FDA, Omalizaumab, binds to IgE Fc region (blocking binding to FcerI)
- high cost, no more effective than second-generation antihistamines and so is not often prescribed
Desensitization/Immunotherapy
- Treatment by repeated exposure of gradually increasing doses of allergen
- injection, application on skin or under tongue
- after maintenance dose is reached (can take up to three years), allergy responses can be eliminated for several years, but not always
What makes up human blood groups?
carbohydrates
Why do we make antibodies for blood groups that are not our own, even if we haven’t been exposed to blood belonging to those groups at some point in our lives?
- adults possess anitbodies to the blood types they do NOT have due to the similarities of these carbs with similar carb antigens on microbes
- if they receive a transfusion of the “wrong” type of blood, their antibodies will quickly attach to the donor blood cells and trigger complement
- the degraded RBC components can build to toxic levels
Explain the mechanism behind a type II hypersensitivity
- massive intravascular hemolysis of RBCs
- free hemoglobin cannot be filtered fast enough and accumulates
- the porphyrin component of hemoglobin is degraded to bilirubin, which is toxic